V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220020339 | 220005666 | 1.84 | 103.4 | Curative (C) | null | 2017-07-14 | FLAG + Idarubicin | null | N | 220021561 | FLAG + IDARUBICIN |
| 220020340 | 220005672 | 1.64 | 81 | Curative (C) | 2018-02-24 | 2018-07-12 | FLAG + Idarubicin | 02 | N | 220021572 | FLAG + IDARUBICIN |
| 220020343 | 220005711 | 1.55 | 116.3 | Curative (C) | 2018-05-28 | 2018-05-30 | AML Interim Guidelines FLAG-Ida | 02 | N | 220021673 | FLAG + IDARUBICIN |
| 220020344 | 220005717 | 1.73 | 68 | Disease modification (D) | 2016-10-04 | 2016-10-04 | AML17 TRIAL | 02 | N | 220021690 | AML17 TRIAL |
| 220020345 | 220019423 | 1.65 | 72.9 | Curative (C) | 2016-02-09 | 2016-06-24 | AML17 TRIAL | Y | N | 220021705 | AML17 TRIAL |
| 220020346 | 220005722 | 1.61 | 99.1 | Curative (C) | 2018-04-26 | 2018-06-08 | FLAG + Idarubicin | Y | N | 220021705 | FLAG + IDARUBICIN |
| 220020347 | 220005725 | 1.52 | 64.3 | Curative (C) | 2018-10-21 | 2018-10-22 | AML17 TRIAL | 02 | N | 220021721 | AML17 TRIAL |
| 220020348 | 220005730 | 1.74 | 140 | Curative (C) | 2015-09-28 | 2015-12-06 | FLAG + Idarubicin | null | null | 220021727 | FLAG + IDARUBICIN |
| 220020349 | 220005736 | 1.75 | 95 | null | 2013-12-12 | 2014-02-17 | AML17 TRIAL | N | null | 220021740 | AML17 TRIAL |
| 220020350 | 220005744 | 1.64 | 91.8 | Disease modification (D) | 2015-04-15 | 2015-04-18 | AML17 TRIAL | 01 | N | 220021755 | AML17 TRIAL |
| 220020351 | 220005753 | 1.79 | 73 | Disease modification (D) | 2013-04-03 | 2013-06-29 | AML17 TRIAL | N | N | 220021780 | AML17 TRIAL |
| 220020352 | 220005756 | 1.52 | 109.9 | Curative (C) | 2016-01-06 | 2016-02-24 | FLAG + Idarubicin | 01 | N | 220021785 | FLAG + IDARUBICIN |
| 220020353 | 220005759 | 1.6 | 95 | Curative (C) | 2017-05-28 | 2017-05-28 | AML17 TRIAL | N | N | 220021789 | AML17 TRIAL |
| 220020354 | 220021412 | 1.57 | 68.2 | Adjuvant (A) | 2014-10-02 | 2015-02-03 | AML17 TRIAL | N | N | 220021792 | AML17 TRIAL |
| 220020355 | 220005767 | 1.63 | 84 | Adjuvant (A) | 2013-05-30 | 2013-07-17 | FLAG + Idarubicin | N | null | 220021803 | FLAG + IDARUBICIN |
| 220020356 | 220005772 | 1.78 | 61.4 | Radical (R) | 2015-09-20 | 2015-09-20 | AML17 TRIAL | 1 | N | 220021810 | AML17 TRIAL |
| 220020357 | 220005779 | 1.76 | 74 | Not known (9) | 2016-06-10 | 2016-06-14 | AML17 TRIAL | N | N | 220021824 | AML17 TRIAL |
| 220020359 | 220005792 | 1.76 | 64 | Disease modification (D) | null | 2013-06-04 | FLAG + Idarubicin | Y | N | 220021861 | FLAG + IDARUBICIN |
| 220020360 | 220005797 | 1.74 | 63.8 | Curative (C) | 2017-10-23 | 2017-10-26 | FLAG + Idarubicin | N | N | 220021889 | FLAG + IDARUBICIN |
| 220020361 | 220005799 | null | 70.2 | Curative (C) | 2018-04-09 | 2018-04-09 | FLAG + Idarubicin | N | Y | 220021890 | FLAG + IDARUBICIN |
| 220020362 | 220005803 | 1.77 | 72.3 | Palliative (P) | 2018-08-16 | 2018-08-21 | FLAG + Idarubicin | Y | null | 220021900 | FLAG + IDARUBICIN |
| 220020363 | 220005806 | null | 57.4 | Curative (C) | 2017-09-28 | 2018-01-04 | FLAG + Idarubicin | N | N | 220021920 | FLAG + IDARUBICIN |
| 220020364 | 220005807 | 1.65 | 46.9 | Curative (C) | 2018-04-25 | 2018-07-04 | AML17 TRIAL | N | N | 220021929 | AML17 TRIAL |
| 220020365 | 220005814 | 1.65 | 76.8 | Curative (C) | 2016-07-19 | 2016-12-15 | AML17 TRIAL | N | N | 220021949 | AML17 TRIAL |
| 220020366 | 220005817 | 1.68 | 76.4 | Curative (C) | 2017-12-19 | 2017-12-20 | AML17 TRIAL | N | N | 220021957 | AML17 TRIAL |
| 220020367 | 220013075 | 1.71 | 89 | Adjuvant (A) | 2013-09-13 | 2014-02-12 | FLAG + Idarubicin | 02 | N | 220021958 | FLAG + IDARUBICIN |
| 220020368 | 220005823 | 0 | 80 | Curative (C) | 2013-08-29 | 2013-08-29 | AML17 TRIAL | N | N | 220021966 | AML17 TRIAL |
| 220020369 | 220005828 | 1.8 | 93.1 | Curative (C) | 2017-08-11 | 2017-09-18 | AML17 TRIAL | N | N | 220021991 | AML17 TRIAL |
| 220020370 | 220005832 | 1.65 | 58.8 | Curative (C) | 2016-06-23 | 2016-08-17 | AML17 TRIAL | N | N | 220021995 | AML17 TRIAL |
| 220020372 | 220005840 | 1.73 | 58 | Disease modification (D) | 2016-05-27 | 2016-05-27 | FLAG + Idarubicin | N | N | 220022012 | FLAG + IDARUBICIN |
| 220020373 | 220005847 | 1.91 | 76.2 | Not known (9) | 2017-06-09 | 2017-06-09 | FLAG + Idarubicin | 02 | N | 220022043 | FLAG + IDARUBICIN |
| 220020374 | 220005850 | 1.78 | 160.4 | Curative (C) | 2016-05-08 | 2016-07-21 | AML17 TRIAL | Y | null | 220022050 | AML17 TRIAL |
| 220020375 | 220013100 | 1.73 | 76 | Not known (9) | 2016-05-18 | 2016-05-26 | AML17 TRIAL | 02 | N | 220022059 | AML17 TRIAL |
| 220020376 | 220013105 | 1.71 | 78 | Curative (C) | 2016-04-08 | 2016-05-12 | AML17 TRIAL | Y | N | 220022092 | AML17 TRIAL |
| 220020377 | 220005861 | null | 94.7 | Curative (C) | 2016-01-12 | 2016-04-01 | AML Interim Guidelines FLAG-Ida | Y | N | 220022100 | FLAG + IDARUBICIN |
| 220020378 | 220005862 | 1.54 | 62.6 | Curative (C) | 2018-02-21 | 2018-02-21 | AML17 TRIAL | N | N | 220022101 | AML17 TRIAL |
| 220020379 | 220005871 | 1.68 | 65 | Curative (C) | 2014-05-25 | 2014-05-29 | FLAG + Idarubicin | null | null | 220022122 | FLAG + IDARUBICIN |
| 220020380 | 220005877 | 1.66 | 92 | Curative (C) | 2017-05-05 | 2017-07-04 | AML17 TRIAL | N | N | 220022134 | AML17 TRIAL |
| 220020381 | 220013116 | 1.7 | 76.4 | Curative (C) | 2013-05-20 | 2013-06-27 | AML17 TRIAL | N | N | 220022138 | AML17 TRIAL |
| 220020382 | 220005887 | null | 93.1 | Curative (C) | 2014-04-30 | 2014-04-30 | FLAG + Idarubicin | N | N | 220022174 | FLAG + IDARUBICIN |
| 220020383 | 220013124 | null | 77.1 | Curative (C) | 2012-11-30 | 2013-03-28 | AML17 TRIAL | N | N | 220022176 | AML17 TRIAL |
| 220020384 | 220005893 | 1.6 | 66.7 | Curative (C) | 2015-04-30 | 2015-08-14 | FLAG + Idarubicin | N | N | 220022187 | FLAG + IDARUBICIN |
| 220020385 | 220005895 | 1.8 | 79 | Curative (C) | 2017-11-13 | 2017-11-13 | FLAG + Idarubicin | N | N | 220022193 | FLAG + IDARUBICIN |
| 220020386 | 220005899 | 1.76 | 82 | Curative (C) | 2014-07-15 | 2014-07-15 | AML17 TRIAL | N | N | 220022212 | AML17 TRIAL |
| 220020387 | 220005905 | 1.57 | 79.2 | null | 2019-02-25 | 2019-04-19 | FLAG + Idarubicin | 01 | N | 220022215 | FLAG + IDARUBICIN |
| 220020388 | 220005913 | 1.62 | 80 | Curative (C) | 2019-02-25 | 2019-02-25 | AML17 TRIAL | null | N | 220022244 | AML17 TRIAL |
| 220020389 | 220005921 | 1.89 | 65.6 | Curative (C) | 2015-07-17 | 2015-07-17 | FLAG + Idarubicin | 02 | N | 220022260 | FLAG + IDARUBICIN |
| 220020390 | 220005926 | 1.79 | 121.5 | Not known (9) | 2017-12-31 | 2018-01-02 | FLAG + Idarubicin | 02 | N | 220022273 | FLAG + IDARUBICIN |
| 220020391 | 220017206 | 1.61 | 58.8 | Adjuvant (A) | 2015-10-19 | 2015-10-20 | AML17 TRIAL | null | null | 220022303 | AML17 TRIAL |
| 220020392 | 220013151 | 1.68 | 83 | Disease modification (D) | 2014-11-19 | 2015-02-16 | AML17 TRIAL | 02 | N | 220022309 | AML17 TRIAL |